9,110 Results

FDA approves Symtuza for HIV-1.- Janssen Pharma.

 Added 1 day ago

Janssen Pharmaceutical announced the FDA has approved Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide), the first and only complete, darunavir-based single-tablet regimen (STR) for...

FDA approves additional indication for Kisqali in HR+/HER2- metastatic breast cancer.- Novartis.

 Added 1 day ago

Novartis announced that the FDA has given approval for Kisqali (ribociclib) for women with hormone-receptor positive, human epidermal growth factor...

Phase III trial of PF 4383119 meets all co-primary endpoints in osteoarthritis pain.- Pfizer + Eli Lilly.

 Added 1 day ago

Pfizer and Eli Lilly announced that a 16-week Phase III study in patients with osteoarthritis (OA) pain evaluating subcutaneous administration...

Tecentriq + Avastin combination in Phase III trial to treat Liver Cancer.- Genentech + Roche.

 Added 1 day ago

Genentech now reports that earlier this year, Genentech initiated IMbrave150 (NCT03434379), an open-label, multicenter, randomized Phase III study investigating the...

CAMELLIA-TIMI 61 outcomes trial of Belviq meets primary endpoint in obesity.- Eisai.

 Added 2 days ago

Eisai announced positive topline results from the CAMELLIA-TIMI 61 cardiovascular outcome trial, a 12,000 patient study of Belviq (lorcaserin HCl)...

Phase III CREDENCE trial of Invokana halted early after efficacy criteria reached in chronic kidney disease and type 2 diabetes.- Janssen.

 Added 2 days ago

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the Phase III CREDENCE (Canagliflozin and Renal Events in Diabetes...

Study shows RGN 259 equal to or better than competition in treating dry eye disease.- RegeneRx Biopharma.

 Added 2 days ago

RegeneRx Biopharmaceutical announced that a new study was published comparing RGN 259 (thymosin beta 4) with currently approved prescription products...

Dermavant Sciences acquires rights to tapinarof from GSK. This is an investigational therapeutic aryl hydrocarbon receptor modulating agent for the treatment of psoriasis and atopic dermatitis.

 Added 2 days ago

GSK has announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purchase the rights to tapinarof, an...

Baloxavir marboxil success in Phase III CAPSTONE-2 study to treat influenza.- Genentech/Roche + Shionogi.

 Added 2 days ago

Genentech, announced that the Phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high...

Load more